Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

Core Insights - Relay Therapeutics is a clinical-stage precision medicine company focused on transforming the drug discovery process through advanced computational and experimental technologies [2] - The company will report its second quarter 2025 financial results and corporate highlights on August 7, 2025, after U.S. financial markets close [1] Company Overview - Relay Therapeutics aims to develop life-changing therapies by integrating cutting-edge computational and experimental techniques [2] - The company utilizes its Dynamo platform to address challenging protein targets in drug discovery, particularly in targeted oncology and genetic diseases [2] Contact Information - Media inquiries can be directed to Dan Budwick at 1AB [3]